Organisation
Medical Oncology
Current researchers
1 - 10 of 21 results
- Sandrine Aspeslagh (Member)
- Gil Awada (Member)
- Ruben De Wilde (Member)
- Lore Decoster (Member)
- Iris Dirven (Member)
- Christel Fontaine (Member)
- Mathijs Goossens (Member)
- Mark Gorris (Member)
- Sofie Joris (Member)
- Koen Kortbeek (Member)
Projects
1 - 2 of 2
- Health-related quality of life, psychosocial outcome and neurocognitive function in metastatic cancer survivors treated with immunotherapy, followed by integrative neurocognitive remediation therapyFrom1 Nov 2022 → TodayFunding: FWO fellowships
- A randomized phase II clinical trial in NSCLC combining SBRT and I.V. anti-PD-1 with or without I.T. anti-CTLA-4/anti-PD-L1 plus CD1c+ myDCFrom1 Oct 2019 → 30 Sep 2023Funding: FWO Applied Biomedical Research (TBM)
Publications
11 - 20 of 281
- Association of homogeneous inflamed gene signature with a better outcome in patients with metastatic melanoma treated with MAGE-A3 immunotherapeutic(2018)
Authors: Jean-François Baurain, Caroline Robert, Laurent Mortier, Bart Neyns, Florent Grange, Céleste Lebbe, Fernando Ulloa-Montoya, Pedro Miguel De Sousa Alves, Marc Gillet, Jamila Louahed, et al.
- Isolated adrenocorticotropic hormone deficiency and sialadenitis associated with nivolumab(2022)
Authors: Sylvain Raoul Simeni Njonnou, Sandrine Aspeslagh, Marie-Josiane Ntsama Essomba, Marie-Lucie Racu, Fernando Kemta Lekpa, Frédéric Vandergheynst
- Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006)(2019)
Authors: Caroline Robert, Antoni Ribas, Jacob Schachter, Ana Arance, Jean-Jacques Grob, Laurent Mortier, Adil Daud, Matteo S Carlino, Catriona M. McNeil, Michal Lotem, et al.
Pages: 1239-1251 - The predictive and prognostic significance of cell-free DNA concentration in melanoma(2021)
Authors: R Váraljai, S Elouali, S S Lueong, Kilian Wistuba-Hamprecht, Teofila Seremet, Jens T Siveke, J C Becker, Antje Sucker, A Paschen, Peter A. Horn, et al.
Pages: 387-395 - An open-label, multicentre safety study of vemurafenib in patients with BRAFV600-mutant metastatic melanoma(2019)
Authors: James Larkin, Michael P Brown, Ana M Arance, Axel Hauschild, Paola Queirolo, Michele Del Vecchio, Paolo A Ascierto, Ivana Krajsová, Jacob Schachter, Bart Neyns, et al.
Pages: 175-185 - Unplanned hospitalizations in older patients with cancer(2021)
Authors: Elke Hilde Lodewijckx, Cindy Kenis, Johan Flamaing, Philip DeBruyne, Inge De Groof, Christian Focan, Frank Cornélis, Vincent Verschaeve, Christian Bachmann, Dominique Bron, et al.
Pages: 368-374 - A prospective analysis of the incidence of breast cancer related lymphedema of the arm after surgery and axillary lymph node dissection in early breast cancer patients treated with concomitant irradiation and anthracyclines followed by Paclitaxel®.(2011)
Authors: Nele Adriaenssens, Hilde Van Parijs, Maria Voordeckers, Jean-François Fils, Denis Schallier
Pages: 20-24 - Updated recommendations of the International Society of Geriatric Oncology on prostate cancer management in older patients(2019)
Authors: H J Boyle, S Alibhai, Lore Decoster, E Efstathiou, K Fizazi, N Mottet, S Oudard, Hannah Payne, M Prentice, M Puts, et al.
Pages: 116-136 - Undetectable circulating tumor DNA (ctDNA) levels correlate with favorable outcome in metastatic melanoma patients treated with anti-PD1 therapy(2019)
Authors: Teofila Seremet, Yanina Jansen, Simon Planken, Hassan Njimi, Melanie Delaunoy, Hakim El Housni, Gil Awada, Julia Katharina Schwarze, Marleen Keyaerts, Hendrik Everaert, et al.
- Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma(2023)
Authors: Emiel A De Jaeghere, Sandra Tuyaerts, An Van Nuffel, Ann Belmans, Kris Bogaerts, Regina E. M. Baiden-Amissah, Lien Lippens, Peter Vuylsteke, Stéphanie Henry, xuan bich trinh, et al.
Pages: 475-491